AR054350A2 - Preparado farmaceutico que contiene acidos difosfonicos para la palicacion por via oral - Google Patents
Preparado farmaceutico que contiene acidos difosfonicos para la palicacion por via oralInfo
- Publication number
- AR054350A2 AR054350A2 ARP060101621A ARP060101621A AR054350A2 AR 054350 A2 AR054350 A2 AR 054350A2 AR P060101621 A ARP060101621 A AR P060101621A AR P060101621 A ARP060101621 A AR P060101621A AR 054350 A2 AR054350 A2 AR 054350A2
- Authority
- AR
- Argentina
- Prior art keywords
- active substance
- acids
- oral
- palication
- diffosphonic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
Composiciones farmacéuticas compatibles por vía oral, para la aplicacion por vía oral, que constan de un nucleo que contiene como sustancias activas derivados de ácidos difosfonicos, el cual está rodeado por una capa de envoltura exenta de sustancia activa. Las formas de presentacion ponen en libertad la sustancia activa independientemente del valor del pH del medio de liberacion. Reivindicacion 1: Forma de presentacion farmacéutica para la aplicacion por vía oral, que contiene como sustancia activa un derivado de ácido difosfonico en una dosificacion de 0,001 hasta 1.000 mg, estando caracterizada la forma de presentacion porque consta de una parte interna que contiene sustancia activa, la cual está rodeada por una envolvente exenta de sustancia activa.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19615812A DE19615812A1 (de) | 1996-04-20 | 1996-04-20 | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR054350A2 true AR054350A2 (es) | 2007-06-20 |
Family
ID=7791961
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101504A AR006652A1 (es) | 1996-04-20 | 1997-04-15 | Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas. |
| ARP060101621A AR054350A2 (es) | 1996-04-20 | 2006-04-24 | Preparado farmaceutico que contiene acidos difosfonicos para la palicacion por via oral |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970101504A AR006652A1 (es) | 1996-04-20 | 1997-04-15 | Forma farmacéutica de dosificación oral para el tratamiento oral de enfermedades óseas. |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6143326A (es) |
| EP (2) | EP0936913B2 (es) |
| JP (2) | JP5037746B2 (es) |
| CN (1) | CN101152160A (es) |
| AR (2) | AR006652A1 (es) |
| AT (1) | ATE404207T1 (es) |
| AU (1) | AU722516B2 (es) |
| BR (1) | BR9708785A (es) |
| CA (1) | CA2251886C (es) |
| CO (1) | CO4820394A1 (es) |
| CZ (1) | CZ297341B6 (es) |
| DE (2) | DE19615812A1 (es) |
| DK (1) | DK0936913T4 (es) |
| ES (1) | ES2313735T5 (es) |
| HU (1) | HU228389B1 (es) |
| IL (2) | IL126655A (es) |
| NO (1) | NO319162B1 (es) |
| NZ (1) | NZ332314A (es) |
| PA (1) | PA8427301A1 (es) |
| PL (2) | PL191910B1 (es) |
| PT (1) | PT936913E (es) |
| RU (1) | RU2193881C2 (es) |
| SI (1) | SI0936913T2 (es) |
| TR (1) | TR199802108T2 (es) |
| WO (1) | WO1997039755A1 (es) |
| ZA (1) | ZA973331B (es) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| HUP0004625A1 (hu) * | 1997-06-11 | 2001-06-28 | The Procter & Gamble Co. | Az emésztőcsatorna felső szakaszának fokozott biztonságot nyújtó filmbevonatos tabletta |
| EP0998932A1 (de) | 1998-10-09 | 2000-05-10 | Boehringer Mannheim Gmbh | Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung |
| AR024462A1 (es) * | 1999-07-01 | 2002-10-02 | Merck & Co Inc | Tabletas farmaceuticas |
| US6476006B2 (en) * | 2000-06-23 | 2002-11-05 | Teva Pharmaceutical Industries, Ltd. | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| US7674480B2 (en) * | 2000-06-23 | 2010-03-09 | Teva Pharmaceutical Industries Ltd. | Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition |
| US6881420B2 (en) * | 2000-06-23 | 2005-04-19 | Teva Pharmaceutical Industries Ltd. | Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation |
| HUP0303700A3 (en) * | 2000-07-17 | 2006-07-28 | Astellas Pharma Inc Chuo Ku | Pharmaceutical composition improved in peroral absorbability |
| JP2002332235A (ja) * | 2001-02-01 | 2002-11-22 | Riderway Corp | 骨疾患治療用液体医薬組成物 |
| AR034199A1 (es) * | 2001-02-01 | 2004-02-04 | Riderway Corp | Composicion farmacologica liquida para el tratamiento de enfermedades oseas y procedimientos para su elaboracion |
| WO2002089816A1 (en) * | 2001-05-02 | 2002-11-14 | Novartis Ag | Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis |
| PL371264A1 (en) * | 2001-12-21 | 2005-06-13 | The Procter & Gamble Company | Method for the treatment of bone disorders |
| SI1476138T1 (sl) | 2002-02-21 | 2012-07-31 | Valeant Internat Barbados Srl | Formulacije s prirejenim sproščanjem vsaj ene oblike tramadola |
| ES2532393T3 (es) * | 2002-05-10 | 2015-03-26 | F. Hoffmann-La Roche Ag | Acidos bisfosfónicos para tratamiento y prevención de osteoporosis |
| GB0229258D0 (en) * | 2002-12-16 | 2003-01-22 | Boots Healthcare Int Ltd | Medicinal compositions |
| DE60315514T3 (de) * | 2002-12-20 | 2012-04-26 | F. Hoffmann-La Roche Ag | Hochdosierte ibandronat-formulierung |
| TR200300510A2 (tr) * | 2003-04-18 | 2004-11-22 | Sanovel �La� Sanay� Ve T�Caret A.�. | Dağılan alendronat mikropartikül formülasyonu |
| GB0403628D0 (en) * | 2004-02-18 | 2004-03-24 | Arrow Group Ltd | Compression-coated tablets and the manufacture thereof |
| US7645459B2 (en) | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of bisphosphonates |
| US20080286359A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US20080287400A1 (en) * | 2004-05-24 | 2008-11-20 | Richard John Dansereau | Low Dosage Forms Of Risedronate Or Its Salts |
| US7645460B2 (en) * | 2004-05-24 | 2010-01-12 | The Procter & Gamble Company | Dosage forms of risedronate |
| US7358361B2 (en) | 2004-10-08 | 2008-04-15 | The Board Of Trustees Of The University Of Illinois | Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
| WO2008128056A1 (en) * | 2004-10-08 | 2008-10-23 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps |
| US20070191315A1 (en) * | 2006-02-16 | 2007-08-16 | Bengt Bergstrom | Method for administering ibandronate |
| JP2009530414A (ja) * | 2006-03-17 | 2009-08-27 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | ビスホスホネート化合物及び方法 |
| KR20090037951A (ko) * | 2006-07-25 | 2009-04-16 | 교와 가부시키가이샤 | 당의 제제 및 그의 제조 방법 |
| GB0616794D0 (en) * | 2006-08-24 | 2006-10-04 | Arrow Int Ltd | Solid dosage form |
| US20080139514A1 (en) * | 2006-11-29 | 2008-06-12 | Subhash Pandurang Gore | Diphosphonic acid pharmaceutical compositions |
| CA2570949A1 (en) * | 2006-12-12 | 2008-06-12 | Apotex Pharmachem Inc. | Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| WO2009075601A1 (fr) * | 2007-12-12 | 2009-06-18 | Alexander Valerievich Melnik | Moyen d'indication d'une éventuelle prédisposition de chats à une maladie (variantes) et procédé de détermination de troubles de la santé chez les chats |
| EP2210596A1 (en) * | 2009-01-22 | 2010-07-28 | Laboratorios Liconsa, S.A. | Pharmaceutical composition of ibandronate sodium salt or a hydrate thereof |
| SI2612681T1 (sl) * | 2010-08-31 | 2019-05-31 | Toray Industries, Inc. | Obložno sredstvo za farmacevtsko trdno obliko, farmacevtska filmska formulacija in obložena farmacevtska trdna oblika |
| PL2720681T3 (pl) | 2011-06-17 | 2017-05-31 | Evonik Röhm Gmbh | Kompozycja powlekająca odpowiednia do farmaceutycznych lub nutraceutycznych postaci dawkowania |
| RU2485957C1 (ru) * | 2012-03-16 | 2013-06-27 | Государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия последипломного образования" Министерства здравоохранения Российской Федерации (ГБОУ ДПО РМАПО Минздрава России) | Средство для лечения низкообменного варианта заболевания скелета у больных с хронической почечной недостаточностью |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE965825C (de) | 1949-10-30 | 1957-06-19 | Walter Kloepfer Dipl Ing Dr In | Zur Antennenebene senkrecht polarisierter Strahler |
| US4820698A (en) * | 1985-11-04 | 1989-04-11 | The Procter & Gamble Company | Antimicrobial agents and process for their manufacture |
| DE3623397A1 (de) * | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
| US5098717A (en) * | 1987-12-09 | 1992-03-24 | Thames Pharmacal Co., Inc. | Method of treatment for pruritus |
| EP0550385A1 (de) * | 1991-12-19 | 1993-07-07 | Ciba-Geigy Ag | Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten |
| TW237386B (es) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
| US5358941A (en) * | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
| AU687744B2 (en) * | 1993-05-15 | 1998-03-05 | Riemser Arzneimittel Ag | More easily biologically absorbed tablet containing dichloromethylene diphosphonic acid as the active agent |
| US5431920A (en) * | 1993-09-21 | 1995-07-11 | Merck Frosst, Canada, Inc. | Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents |
| TW390813B (en) * | 1994-04-29 | 2000-05-21 | Merck & Co Inc | Wet granulation formulation for bisphosphonic acids |
| DE19615812A1 (de) * | 1996-04-20 | 1997-10-23 | Boehringer Mannheim Gmbh | Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation |
| US5803321A (en) * | 1996-11-12 | 1998-09-08 | Randy Hangers, Lll | Hanger with ganging element |
| US20060045865A1 (en) * | 2004-08-27 | 2006-03-02 | Spherics, Inc. | Controlled regional oral delivery |
-
1996
- 1996-04-20 DE DE19615812A patent/DE19615812A1/de not_active Withdrawn
-
1997
- 1997-04-08 CO CO97017783A patent/CO4820394A1/es unknown
- 1997-04-15 AR ARP970101504A patent/AR006652A1/es active IP Right Grant
- 1997-04-17 PA PA19978427301A patent/PA8427301A1/es unknown
- 1997-04-18 ZA ZA973331A patent/ZA973331B/xx unknown
- 1997-04-21 NZ NZ332314A patent/NZ332314A/xx not_active IP Right Cessation
- 1997-04-21 CA CA002251886A patent/CA2251886C/en not_active Expired - Lifetime
- 1997-04-21 CN CNA2007101536726A patent/CN101152160A/zh active Pending
- 1997-04-21 WO PCT/EP1997/001940 patent/WO1997039755A1/de active IP Right Grant
- 1997-04-21 SI SI9730781T patent/SI0936913T2/sl unknown
- 1997-04-21 BR BR9708785A patent/BR9708785A/pt not_active Application Discontinuation
- 1997-04-21 PL PL369034A patent/PL191910B1/pl unknown
- 1997-04-21 US US09/147,149 patent/US6143326A/en not_active Expired - Lifetime
- 1997-04-21 AT AT97918146T patent/ATE404207T1/de active
- 1997-04-21 TR TR1998/02108T patent/TR199802108T2/xx unknown
- 1997-04-21 ES ES97918146T patent/ES2313735T5/es not_active Expired - Lifetime
- 1997-04-21 DK DK97918146.8T patent/DK0936913T4/da active
- 1997-04-21 RU RU98120909/14A patent/RU2193881C2/ru active
- 1997-04-21 DE DE59712959T patent/DE59712959D1/de not_active Expired - Lifetime
- 1997-04-21 IL IL12665597A patent/IL126655A/en not_active IP Right Cessation
- 1997-04-21 IL IL16393097A patent/IL163930A0/xx unknown
- 1997-04-21 PT PT97918146T patent/PT936913E/pt unknown
- 1997-04-21 AU AU26382/97A patent/AU722516B2/en not_active Expired
- 1997-04-21 PL PL329347A patent/PL191363B1/pl unknown
- 1997-04-21 CZ CZ0336498A patent/CZ297341B6/cs not_active IP Right Cessation
- 1997-04-21 JP JP53771197A patent/JP5037746B2/ja not_active Expired - Lifetime
- 1997-04-21 EP EP97918146A patent/EP0936913B2/de not_active Expired - Lifetime
- 1997-04-21 EP EP06001911.4A patent/EP1658852B1/de not_active Revoked
- 1997-04-21 HU HU9903407A patent/HU228389B1/hu unknown
-
1998
- 1998-10-19 NO NO19984881A patent/NO319162B1/no not_active IP Right Cessation
-
2003
- 2003-09-12 US US10/660,785 patent/US20050089573A1/en not_active Abandoned
-
2006
- 2006-04-24 AR ARP060101621A patent/AR054350A2/es unknown
-
2008
- 2008-07-08 JP JP2008178294A patent/JP5557989B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR054350A2 (es) | Preparado farmaceutico que contiene acidos difosfonicos para la palicacion por via oral | |
| ES2181055T3 (es) | Formulaciones galenicas que contienen antagonistas de opiaceos. | |
| CO6150127A2 (es) | Formulaciones de flibanserina y metodo para fabricarlas | |
| HRP20040323C1 (hr) | Oralni oblici davanja propiverina ili njegovih farmaceutski prihvatljivih soli s produljenim oslobađanjem djelotvone supstance | |
| AR046773A1 (es) | Formulaciones farmaceuticas de bisfosfonatos | |
| ES2178430T3 (es) | Utilizacion de composiciones farmaceuticas gelificables en parodontologia. | |
| HK1096034A1 (en) | A solid dosage form comprising a fibrate | |
| CO5271759A1 (es) | Formulacion en solucion que contiene una mezcla de disolventes | |
| HUP0302086A2 (hu) | Késleltetett hatású orális gyógyászati készítmény és eljárás az előállítására | |
| AR019690A1 (es) | Formulacion farmaceutica para aerosoles con dos o mas sustancias activas | |
| ES2060825T3 (es) | Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa. | |
| AR059723A2 (es) | Composicion de altas dosis de ibandronato | |
| BR0208382A (pt) | Forma de dosagem oral contendo nicotina | |
| PE20050066A1 (es) | Formulaciones farmaceuticas liquidas de palonosetron | |
| DE60134021D1 (de) | Pharmazeutische zubereitungen zur angiogenese-therapie | |
| UY27969A1 (es) | Formulaciones que comprenden un compuesto de indolinona | |
| HUP0302635A2 (hu) | Valpronsav foszfolipidszármazékai és ezek keveréke | |
| BR0013719A (pt) | Dosagem oral de liberaçâo controlada, apropriada para administração oral | |
| DE60030283D1 (de) | Zusammensetzungen zur erhöhung der bioverfügbarkeit von oral verabreichten pharmazeutischen verbindungen | |
| AR023138A1 (es) | Composicion para gomas de mascar medicadas, proceso de fabricacion y tabletas obtenidas con dicho proceso | |
| AR022621A1 (es) | Composicion farmaceutica que contiene desoxipeganina para el tratamiento de la dependencia de la nicotina | |
| ECSP972082A (es) | Preparado farmaceutico que contiene acidos difosforicos para la aplicación por via oral | |
| ECSP003508A (es) | Formas polimorfas de un citrato de azobiciclo [2.2.2] octan-3-amina y sus composiciones farmaceuticas | |
| IT1293835B1 (it) | Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione | |
| HN1999000174A (es) | Formulacion medicamentosa acuisa para administracion oral. |